Dr Norhafizah Hamzah – Awards and Publications
Consultant Ophthalmologist, Paediatric Ophthalmologist & Squint Surgeon
Kuala Lumpur
- Excellence Service award Year 2013 and 2024
1. Nor-Aizura, Z., et al. (including Hamzah, N.) (2025). Factors associated with mortality among retinoblastoma patients in Malaysia: A retrospective cohort study. The Medical journal of Malaysia, 80(Suppl 6), 1–7.
PMID: 41446994
2. Wai, Y. Z., et al. (including Hamzah, N.) (2022). Familial exudative vitreoretinopathy in a 4 generations family of South-East Asian Descendent with FZD4 mutation (c.1501_1502del). International journal of retina and vitreous, 8(1), 30.
DOI: 10.1186/s40942-022-00384-2
3. Wai, Y. Z., et al. (including Hamzah, N.) (2023). Intra-arterial chemotherapy for retinoblastoma: Experience from the pediatric ophthalmology referral center in Malaysia with literature review. Taiwan Journal of Ophthalmology, 13(4), 527–534.
DOI: 10.4103/tjo.TJO-D-22-00162
4. Global Retinoblastoma Study Group. (2022). The Global Retinoblastoma Outcome Study: A prospective, cluster-based analysis of 4064 patients from 149 countries. The Lancet Global Health, 10(8), e1128–e1140.
DOI: 10.1016/S2214-109X(22)00250-9